Morphine-induced RACK1-dependent Autophagy in Immortalized Neuronal Cell Lines
Overview
Authors
Affiliations
Background And Purpose: Autophagy is a critical cellular catabolic process in cell homoeostasis and brain function. Recent studies indicate that receptor for activated C kinase 1 (RACK1) is involved in autophagosome formation in Drosophila and mice, and that it plays an essential role in morphine-associated memory. However, the exact mechanism of the role of RACK1 in morphine-induced autophagy is not fully understood.
Experimental Approach: SH-SY5Y cells were cultured and morphine, rapamycin, 3-methyladenine and RACK1 siRNA were used to evaluate the regulation of RACK1 protein in autophagy. Western blotting and immunofluorescence were used to assess protein expression.
Key Results: Activation of autophagy (i.e. autophagosome accumulation and an increase in the LC3-II/LC3-I ratio) induced by morphine contributes to the maintenance of conditioned place preference (CPP) memory in mice. Moreover, morphine treatment significantly increased Beclin-1 expression and decreased the p-mTOR/mTOR and SQSTM1/p62 levels, whereas knockdown of RACK1 prevented morphine-induced autophagy in vitro. Furthermore, we found that in the mouse hippocampus, knockdown of RACK1 also markedly suppressed morphine-induced autophagy (decreased LC3-II/LC3-I ratio and increased p-mTOR/mTOR ratio). Importantly, morphine-induced autophagy in a RACK1-dependent manner. Conversely, morphine-induced RACK1 upregulation in vitro is partially inhibited by autophagy feedback.
Conclusions And Implications: Our findings revealed a critical role for RACK1-dependent autophagy in morphine-promoted maintenance of CPP memory in mice and supported the notion that control of RACK1-dependent autophagic pathways may become an important target for novel therapeutics for morphine-associated memory.
Yu B, Weng L, Li J, Wang T, Qiu W, Li Y Shock. 2024; 63(2):255-266.
PMID: 39527461 PMC: 11776882. DOI: 10.1097/SHK.0000000000002505.
Modulation of autophagy by melatonin and its receptors: implications in brain disorders.
Zhu C, Li G, Lyu H, Lu Y, Li Y, Zhang X Acta Pharmacol Sin. 2024; 46(3):525-538.
PMID: 39448859 PMC: 11845611. DOI: 10.1038/s41401-024-01398-2.
Ma J, Zou L, Lou Y, Lin Y, Zhou J, Ju N Heliyon. 2024; 10(11):e31605.
PMID: 38882370 PMC: 11180326. DOI: 10.1016/j.heliyon.2024.e31605.
Ni H, Kan X, Rui Q, Zhang Y, Zhai W, Zhang B CNS Neurosci Ther. 2024; 30(3):e14691.
PMID: 38532543 PMC: 10966134. DOI: 10.1111/cns.14691.
Huang X, Yan X, Chen G, Feng Y, Bai Y, Yan P Psychopharmacology (Berl). 2023; 241(2):291-304.
PMID: 38049617 DOI: 10.1007/s00213-023-06485-6.